Bryan Quinn

Bryan Quinn is a partner in Goodwin’s Technology group and a member of the firm’s Capital Markets practice. He represents clients on a broad range of corporate and securities law matters, including capital markets transactions, corporate governance, and mergers and acquisitions.

In capital markets, Bryan advises companies and investment banks on private financings, initial public offerings and other going public transactions, and public company financing transactions, including equity, debt and convertible debt offerings. He also advises companies and investors on corporate governance matters, including capital structure, public company reporting and SEC compliance. His merger and acquisition experience includes both buy-side and sell-side representations of public and private companies.

Initial Public Offerings

• DCM in connection with the $41 million initial public offering of American Depositary Shares of QuantaSing Group Limited, a leading online learning service provider in China
• DCM in connection with the $41 million initial public offering of American Depositary Shares of GigaCloud Technology Inc
• A leading provider of a cloud-native platform for software development and IT operations in its $603 million initial public offering of common stock*
• The CEO and co-founder of a leading search engine in connection with its $1.4 billion initial public offering and dual-class common stock recapitalization*
• Various underwriters in the $656 million initial public offering of a leading ultra low-cost airline*
• Various underwriters in the $219 million initial public offering of a leading TV streaming platform*
• Various underwriters in the $112 million initial public offering of a leading cybersecurity solutions provider*
• Various underwriters in the $410 million initial public offering of a leading cloud hosting and domain name marketplace*
• Various underwriters in the $56 million initial public offering of a leading provider of enterprise, cloud-based incentive compensation solutions*
• Various underwriters in the $345 million initial public offering of a SPAC focused on the cybersecurity industry sector*
• Various underwriters in the $230 million initial public offering of a clinical stage immuno-oncology company developing tumor-targeted therapies*
• Various underwriters in the $113 million initial public offering of a clinical stage immune-oncology company developing novel checkpoint therapies to activate macrophages*
• Various underwriters in the $48 million initial public offering of a specialty pharmaceutical company focused on chronic disorders of the central nervous system*
• Various underwriters in the $85 million initial public offering of a clinical biologics platform company focused on the global biosimilar market* 

Other Equity Offerings

• Mirion Technologies in connection with its $86 million debut secondary underwritten offering of its Class A common stock
• Various underwriters in connection with a $74 million secondary offering by NAPCO Security Technologies of its common stock
• Nutrabolt in its strategic partnership with Keurig Dr Pepper (KDP), including a $863 million investment by KDP of $863 million in Nutrabolt 
• The underwriter in a $17 million follow-on offering by SkyWater Technology and the sales agent on SkyWater Technology's $100 million at-the-market offering
• Various underwriters in connection with a $282 million follow-on offering of common stock of a leading EV charging network provider*
• The sales agent in connection with a $500 million at-the-market offering*
• Various underwriters in connection with a $528 million follow-on offering of a retailer of consumables and fresh products*
• Various underwriters in connection with a $138 million follow-on offering of common stock of a clinical-stage biotechnology company developing next-generation human enzyme therapeutics*
• Various underwriters in connection with a $347 million follow-on offering of common stock of a biopharmaceutical company focused on the development and commercialization of new medications targeted at inflammatory disorders, autoimmune diseases and cancer*
• Various underwriters in connection with a $575 million follow-on offering of common stock of a biotechnology company focused on the development and commercialization of targeted therapies for the treatment of cancer*
• Various underwriters in connection with a $115 million follow-on offering of common stock of a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed*

Convertible Debt Offerings

• The lead investor in connection with its investment in $300 million of convertible senior notes offered by a leading EV charging network provider*
• A leading provider of specialty memory, storage and hybrid solutions in connection with its $250 million convertible senior notes offering*
• Various underwriters in connection with a $1.2 billion offering of convertible senior notes by a leading provider of business intelligence software*
• Various underwriters in connection with a $600 million offering of convertible senior notes by leading global manufacturer and supplier of discrete semiconductor*
• A leading solar technology and energy services provider in connection with its $400 million offering of convertible senior notes*

Debt Offerings

• Multiple high-yield and investment grade debt offerings by a leading financial services company providing brokerage services and related products*
• A leading datacenter provider in connection with its $1.3 billion inaugural green bonds offering*
• Various underwriters in connection with a $20 billion investment-grade senior notes offering by a leading provider of enterprise information technology*
• Various underwriters in connection with a $4 billion investment-grade senior notes offering by a leading digital payments company*
• Various underwriters in connection with a $575 million high-yield senior notes offering by a leading provider of search technology*
• Various underwriters in connection with a $550 million investment-grade senior notes offering by a holding company for a group of insurance companies*

SPAC Business Combinations

• Mirion Technologies, a leading provider of products, services and software that leverage ionizing radiation in medical and industrial applications, in its business combination with a special purpose acquisition company (SPAC)*
• A leading provider of casual games in its business combination with a SPAC*

Corporate Governance and Public Company Advice

• Bryan regularly provides general corporate advice on corporate governance and SEC public reporting matters for various companies, including Mirion Technologies, Nutrabolt and thredUP.

Mergers & Acquisitions

• A leading provider of a cloud-native platform for software development and IT operations in its $2.7 billion sale to a leading provider of software virtualization technologies*
• The special committee of a leading semiconductor company in its $37 billion sale to a global supplier of analog semiconductor devices*
• A leading provider of DNA microarray products in its $1.2 billion sale to a leading provider of products for scientists*
• The special committee of a leading industrial company in its $483 million go-private sale to a consortium of private equity funds*
• Private company financings and capital restructurings for multiple companies*

*Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Bryan was counsel in the Northern California office of Davis Polk. Before starting his legal career at Davis Polk, he worked for public and private software companies in various business and technical roles.

Bryan has been named a California Rising Star by Super Lawyers.